Jump to Content

News & Insights

Pharmaceuticals & Healthcare Technologies
  • Israeli Supreme Court: Sanofi Owes Unipharm Restitution for Patent Deception

    By Daniel Lerner; Richard Luthi
    The Israeli Supreme Court has rendered its important and controversial decision in the Sanofi v. Unipharm case, holding that a Patent Applicant who intentionally deceives the Patent Office in order to obtain a patent, may be liable, under the Israeli law of unjust enrichment, to pay generic competitors who delayed entering the market at risk because of this patent application, restitution of the profits gained at their expense as a result of this deception.
    Read more
  • World AIDS Day and Patent Complexities

    By Daniel Lerner; Richard Luthi
    In the four decades that have passed since the fatal AIDS disease erupted in 1981, considerable efforts were and continue to be invested into developing treatments. This has been largely successful. Today AIDS is no longer a life-threatening disease. The first breakthrough occurred when scientists succeeded in identifying the…
    Read more
  • Israeli Innovators at the Forefront of Brain Health Solutions

    By Zvi Jacobson; Ayelet Shwartz
    World Brain Day 2023 was celebrated on July 22 as an initiative of the World Federation of Neurology (WFN), using the slogan "Brain Health and Disability: Leave No One Behind." Recognizing the importance of the day, we decided to give a platform to a number of trends and pioneering companies in the field and tell about their contribution to the latest developments intended to save lives and improve the quality of life.
    Read more
  • World Diabetes Day – 2022

    By Ilan Cohn, PhD; Myriam Schnur
    November 14 was designated by the United Nations as World Diabetes Day. The prevalence of diabetes has increased dramatically over recent decades and reached a global epidemic level, with major health and health economic consequences worldwide.
    Read more
  • Israeli Knesset Backs Law Boosting Local Generic Pharma’s Global Edge

    By Ilan Cohn, PhD; Mirit Lotan, PhD
    The Israeli Parliament (the Knesset) has voted, in a first reading, in favor of a proposed amendment to the Israeli Patents Law (1967) that aims to increase the global competitive advantage of Israeli generic pharmaceutical companies.
    Read more
  • COVID-19 Patent Disputes Expand to Europe

    By Ilan Cohn, PhD; Mirit Lotan, PhD
    The unprecedented success of the COVID-19 vaccines, both therapeutically and commercially, has prompted fierce competition. Multiple companies around the world are fighting to claim patent rights related to these vaccines.
    Read more
  • Ten Years into the CRISPR Revolution – Patent Disputes Continue

    By Ilan Cohn, PhD; Mirit Lotan, PhD
    As the New York Times recently reported, ten years have passed since the first publication of a ground-breaking paper about the potential usefulness of CRISPR, “the gene-editing technology [that] has led to innovations in medicine, evolution and agriculture — and raised profound ethical questions about altering human DNA.”
    Read more
  • Patenting Antibodies in the US and the EU

    By Ilan Cohn, PhD; Mirit Lotan, PhD
    Antibody-based therapeutics play a central role in medicine and patent protection is critical to reaping the financial benefits from such successful therapeutic agents. Recent occurrences suggest that the barriers to securing broad patent protection in the US have increased. Innovative companies should develop and practice proper patent strategies ensuring that they receive the proper exclusionary patent protection that antibody-related innovations deserve.
    Read more
Contact Us Contact Us